BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang X, Li X, Yuan M, Tian C, Yang Y, Wang X, Zhang X, Sun Y, He T, Han S, Chen G, Liu N, Gao Y, Hu D, Xing Y, Shang H. Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms. Front Pharmacol 2018;9:1058. [PMID: 30386232 DOI: 10.3389/fphar.2018.01058] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Mędrek S, Szmit S. Are cardiovascular comorbidities always associated with a worse prognosis in patients with lung cancer? Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.984951] [Reference Citation Analysis]
2 Kim KH, Oh J, Yang G, Lee J, Kim J, Gwak SY, Cho I, Lee SH, Byun HK, Choi HK, Kim J, Chang JS, Kang SM, Yoon HI. Association of Sinoatrial Node Radiation Dose With Atrial Fibrillation and Mortality in Patients With Lung Cancer. JAMA Oncol 2022. [PMID: 36136325 DOI: 10.1001/jamaoncol.2022.4202] [Reference Citation Analysis]
3 Abraham S, Manohar SA, Patel R, Saji AM, Dani SS, Ganatra S. Strategies for Cardio-Oncology Care During the COVID-19 Pandemic. Curr Treat Options Cardio Med. [DOI: 10.1007/s11936-022-00965-2] [Reference Citation Analysis]
4 Bungo B, Chaudhury P, Arustamyan M, Rikhi R, Hussain M, Collier P, Kanj M, Khorana AA, Mentias A, Moudgil R. Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA2DS2VASC score: CCHA2DS2VASC score. IJC Heart & Vasculature 2022;41:101072. [DOI: 10.1016/j.ijcha.2022.101072] [Reference Citation Analysis]
5 Panpan T, Yuchen D, Xianyong S, Meng L, Ruijuan H, Ranran D, Pengyan Z, Mingxi L, Rongrong X. Cardiac Remodelling Following Cancer Therapy: A Review. Cardiovasc Toxicol 2022. [PMID: 35877038 DOI: 10.1007/s12012-022-09762-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kobo O, Moledina SM, Raisi-Estabragh Z, Shanmuganathan JWD, Chieffo A, Al Ayoubi F, Alraies MC, Biondi-Zoccai G, Elgendy IY, Mohamed MO, Roguin A, Freeman P, Mamas MA. Emergency department cardiovascular disease encounters and associated mortality in patients with cancer: A study of 20.6 million records from the USA. Int J Cardiol 2022:S0167-5273(22)01005-1. [PMID: 35752208 DOI: 10.1016/j.ijcard.2022.06.053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Liu BY, Rehmani S, Kale MS, Marshall D, Rosenzweig KE, Kong CY, Wisnivesky J, Sigel K. Risk of Cardiovascular Toxicity According to Tumor Laterality Among Older Patients With Early Stage Non-small Cell Lung Cancer Treated With Radiation Therapy. Chest 2022;161:1666-1674. [DOI: 10.1016/j.chest.2021.12.667] [Reference Citation Analysis]
8 Ahmad J, Thurlapati A, Thotamgari S, Grewal US, Sheth AR, Gupta D, Beedupalli K, Dominic P. Anti-cancer Drugs Associated Atrial Fibrillation—An Analysis of Real-World Pharmacovigilance Data. Front Cardiovasc Med 2022;9:739044. [DOI: 10.3389/fcvm.2022.739044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ai Y, Xing Y, Yan L, Ma D, Gao A, Xu Q, Zhang S, Mao T, Pan Q, Ma X, Zhang J. Atrial Fibrillation and Depression: A Bibliometric Analysis From 2001 to 2021. Front Cardiovasc Med 2022;9:775329. [DOI: 10.3389/fcvm.2022.775329] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
10 Kumar M, Lopetegui-Lia N, Malouf CA, Almnajam M, Coll PP, Kim AS. Atrial fibrillation in older adults with cancer. J Geriatr Cardiol 2022;19:1-8. [PMID: 35233218 DOI: 10.11909/j.issn.1671-5411.2022.01.001] [Reference Citation Analysis]
11 Ostroumova OD, Chernyaeva MS, Kochetkov AI, Vorobieva AE, Bakhteeva DI, Korchagina SP, Bondarets OV, Boyko ND, Sychev DA. Drug-Induced Atrial Fibrillation / Atrial Flutter. Racionalʹnaâ farmakoterapiâ v kardiologii 2022;17:1-18. [DOI: 10.20996/1819-6446-2021-12-11] [Reference Citation Analysis]
12 Vasyuk YA, Shupenina EY, Vyzhigin DA, Novosel EO, Gallinger KV. Atrial Fibrillation in Cancer Patients: Who is at Risk? Racionalʹnaâ farmakoterapiâ v kardiologii 2022;17:900-7. [DOI: 10.20996/1819-6446-2021-12-03] [Reference Citation Analysis]
13 Apostolović-stojanović M, Radojković M, Stojanović A, Vukomanović V. Cardiotoxicity of high-dose methylprednisolone in patients with chronic lymphocytic leukemia: A case report. Srpski medicinski časopis Lekarske komore 2022;3:228-233. [DOI: 10.5937/smclk3-36683] [Reference Citation Analysis]
14 Kobo O, Khattak S, Lopez-Mattei J, Van Spall HGC, Graham M, Cheng RK, Osman M, Sun L, Ullah W, Fischman DL, Roguin A, Mohamed MO, Mamas MA. Trends in cardiovascular mortality of cancer patients in the US over two decades 1999-2019. Int J Clin Pract 2021;75:e14841. [PMID: 34514707 DOI: 10.1111/ijcp.14841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Matetic A, Mohamed M, Miller RJH, Kolman L, Lopez-Mattei J, Cheung WY, Brenner DR, Van Spall HGC, Graham M, Bianco C, Mamas MA. Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions. Int J Cardiol 2021:S0167-5273(21)01197-9. [PMID: 34333019 DOI: 10.1016/j.ijcard.2021.07.054] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
16 Hussain M, Misbah R, Donnellan E, Alkharabsheh S, Hou Y, Cheng F, Crookshanks M, Watson CJ, Toth AJ, Houghtaling P, Moudgil R, Budd GT, Tang WHW, Kwon DH, Jaber W, Griffin B, Kanj M, Collier P. Impact of timing of atrial fibrillation, CHA2DS2-VASc score and cancer therapeutics on mortality in oncology patients. Open Heart 2020;7:e001412. [PMID: 33243931 DOI: 10.1136/openhrt-2020-001412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Siontis KC, Noseworthy PA, Ruddy KJ. Atrial Fibrillation and Cancer: Where Biology and Epidemiology Intertwine. JACC CardioOncol 2021;3:233-5. [PMID: 34396328 DOI: 10.1016/j.jaccao.2021.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yang X, Li G, Guan M, Bapat A, Dai Q, Zhong C, Yang T, Luo C, An N, Liu W, Yang F, Pan H, Wang P, Gao Y, Gong Y, Das S, Shang H, Xing Y. Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis. Front Cardiovasc Med 2021;8:651269. [PMID: 34150864 DOI: 10.3389/fcvm.2021.651269] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
19 Menichelli D, Vicario T, Ameri P, Toma M, Violi F, Pignatelli P, Pastori D. Cancer and atrial fibrillation: Epidemiology, mechanisms, and anticoagulation treatment. Prog Cardiovasc Dis 2021;66:28-36. [PMID: 33915139 DOI: 10.1016/j.pcad.2021.04.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
20 Lee C, Maan A, Singh JP, Fradley MG. Arrhythmias and device therapies in patients with cancer therapy-induced cardiomyopathy. Heart Rhythm 2021;18:1223-9. [PMID: 33640446 DOI: 10.1016/j.hrthm.2021.02.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ren M, Yao Y, Yue X, Ning Y, Yang Y. Atrial Cardiomyopathy and Atrial Fibrillation in Cancer. Cardiol Res Pract 2021;2021:6685953. [PMID: 33628492 DOI: 10.1155/2021/6685953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Leonova MV. Drug-induced arrhythmias. Medicinskij sovet 2021. [DOI: 10.21518/2079-701x-2020-21-26-40] [Reference Citation Analysis]
23 Ostroumova OD, Chernyaeva MS, Kochetkov AI, Bakhteeva DI, Ivanov SN, Sychev DA. Atrial Fibrillation Associated with Anticancer Drugs. Bezopasnost' i risk farmakoterapii 2020;8:178-190. [DOI: 10.30895/2312-7821-2020-8-4-178-190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Yang X, Li G, Yang T, Guan M, An N, Yang F, Dai Q, Zhong C, Luo C, Gao Y, Das S, Xing Y, Shang H. Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity. Oxid Med Cell Longev 2020;2020:4894625. [PMID: 33110473 DOI: 10.1155/2020/4894625] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
25 Zamorano JL, Gottfridsson C, Asteggiano R, Atar D, Badimon L, Bax JJ, Cardinale D, Cardone A, Feijen EAM, Ferdinandy P, López-Fernández T, Gale CP, Maduro JH, Moslehi J, Omland T, Plana Gomez JC, Scott J, Suter TM, Minotti G. The cancer patient and cardiology. Eur J Heart Fail 2020;22:2290-309. [PMID: 32809231 DOI: 10.1002/ejhf.1985] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 16.5] [Reference Citation Analysis]
26 Tisdale JE, Chung MK, Campbell KB, Hammadah M, Joglar JA, Leclerc J, Rajagopalan B;  American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing. Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association. Circulation. 2020;142:e214-e233. [PMID: 32929996 DOI: 10.1161/cir.0000000000000905] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 29.5] [Reference Citation Analysis]
27 Keramida K, Filippatos G, Farmakis D. Cancer treatment and atrial fibrillation: use of pharmacovigilance databases to detect cardiotoxicity. Eur Heart J Cardiovasc Pharmacother 2021;7:321-3. [PMID: 32633808 DOI: 10.1093/ehjcvp/pvaa059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Vasyuk YA, Shupenina EY, Novosel EO, Agapov IS. Heart rhythm and conduction disorders as manifestations of cardiotoxicity of anticancer treatment: myth or reality? SMJ 2020;35:13-21. [DOI: 10.29001/2073-8552-2020-35-1-13-21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Yang X, An N, Zhong C, Guan M, Jiang Y, Li X, Zhang H, Wang L, Ruan Y, Gao Y, Liu N, Shang H, Xing Y. Enhanced cardiomyocyte reactive oxygen species signaling promotes ibrutinib-induced atrial fibrillation. Redox Biol 2020;30:101432. [PMID: 31986467 DOI: 10.1016/j.redox.2020.101432] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
30 Alomar M, Fradley MG. Electrophysiology Translational Considerations in Cardio-Oncology: QT and Beyond. J of Cardiovasc Trans Res 2020;13:390-401. [DOI: 10.1007/s12265-019-09924-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
31 An N, Gao Y, Si Z, Zhang H, Wang L, Tian C, Yuan M, Yang X, Li X, Shang H, Xiong X, Xing Y. Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases. Front Immunol. 2019;10:1592. [PMID: 31354731 DOI: 10.3389/fimmu.2019.01592] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 23.7] [Reference Citation Analysis]
32 Anwar MA, El-Baba C, Elnaggar MH, Elkholy YO, Mottawea M, Johar D, Al Shehabi TS, Kobeissy F, Moussalem C, Massaad E, Omeis I, Darwiche N, Eid AH. Novel therapeutic strategies for spinal osteosarcomas. Semin Cancer Biol 2020;64:83-92. [PMID: 31152785 DOI: 10.1016/j.semcancer.2019.05.018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]